In this study, we focused on the functional analysis of the hypoxia-regulated gene EGLN3. Based on our ligandomics analysis, 13 EGLN3-derived peptides were ccRCC-specifically presented, two of which were among the most frequently presented peptides. This evidence concerns the gene EGLN3 and nonpapillary renal cell carcinoma.